Lipoic acid supplementation associated with neural epidermal growth factor-like 1 (NELL1)–associated membranous nephropathy

Lipoic acid (alpha lipoic acid, thioctic acid) is a popular over-the-counter antioxidant and insulin-mimetic supplement under investigation in a variety of conditions including multiple sclerosis, diabetes, and schizophrenia. Unfortunately, high-grade proteinuria was an unexpected adverse event spec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Kidney international 2021-12, Vol.100 (6), p.1208-1213
Hauptverfasser: Spain, Rebecca I., Andeen, Nicole K., Gibson, Pamela C., Samuels, Mary H., Morris, Cynthia D., Solomon, Andrew J., Solomon, Richard, Waslo, Carin, Avasare, Rupali S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1213
container_issue 6
container_start_page 1208
container_title Kidney international
container_volume 100
creator Spain, Rebecca I.
Andeen, Nicole K.
Gibson, Pamela C.
Samuels, Mary H.
Morris, Cynthia D.
Solomon, Andrew J.
Solomon, Richard
Waslo, Carin
Avasare, Rupali S.
description Lipoic acid (alpha lipoic acid, thioctic acid) is a popular over-the-counter antioxidant and insulin-mimetic supplement under investigation in a variety of conditions including multiple sclerosis, diabetes, and schizophrenia. Unfortunately, high-grade proteinuria was an unexpected adverse event specific to the treatment arm of our clinical trial investigating lipoic acid supplementation in patients with multiple sclerosis. This observation led to detection of similar patients in our nephrology practice. Here, we describe four biopsy-proven cases of neural epidermal growth factor-like 1 (NELL1)–associated membranous nephropathy following lipoic acid supplementation and a fifth suspected case. Discontinuation of lipoic acid and supportive therapy resulted in remission. [Display omitted]
doi_str_mv 10.1016/j.kint.2021.10.010
format Article
fullrecord <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8628858</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0085253821009467</els_id><sourcerecordid>S0085253821009467</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-785e1192a52a1299466c80279a622baf1510961d96886bb47ae638ab1ded99633</originalsourceid><addsrcrecordid>eNp9UcFOGzEQtVARBMoP9FDtsT1ssL2xY0tVpQpBQVrRS3u2Zu0JcciuV7YD4lCp_8Af8iV1FED00pPHz_Pe-M0j5AOjU0aZPF1Nb_2Qp5xyVoApZXSPTJjgTc3mQrwjE0qVqLlo1CE5SmlFy1039IAcNjMpuRR0Qn63fgzeVmC9q9JmHNfY45Ah-zBUkFKwHjK66t7nZTXgJsK6wtE7jH2pbmK4L_gCbA6xXvtbrFj16fq8bdnnpz-Pb_g99l2EIWxSURmXMYyQlw_vyf4C1glPns9j8uvi_OfZZd3--H519q2t7UyIXM-VQMY0B8GBca3L762ifK5Bct7BgglGtWROS6Vk183mgLJR0DGHTmvZNMfk60533HQ9OlscFiNmjL6H-GACePPvy-CX5ibcGSW5UkIVAb4TsDGkFHHxymXUbMMwK7MNw2zD2GIljEL6-HbqK-Vl-6Xhy64Bi_c7j9Ek63Gw6HxEm40L_n_6fwHpmp8o</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Lipoic acid supplementation associated with neural epidermal growth factor-like 1 (NELL1)–associated membranous nephropathy</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Spain, Rebecca I. ; Andeen, Nicole K. ; Gibson, Pamela C. ; Samuels, Mary H. ; Morris, Cynthia D. ; Solomon, Andrew J. ; Solomon, Richard ; Waslo, Carin ; Avasare, Rupali S.</creator><creatorcontrib>Spain, Rebecca I. ; Andeen, Nicole K. ; Gibson, Pamela C. ; Samuels, Mary H. ; Morris, Cynthia D. ; Solomon, Andrew J. ; Solomon, Richard ; Waslo, Carin ; Avasare, Rupali S.</creatorcontrib><description>Lipoic acid (alpha lipoic acid, thioctic acid) is a popular over-the-counter antioxidant and insulin-mimetic supplement under investigation in a variety of conditions including multiple sclerosis, diabetes, and schizophrenia. Unfortunately, high-grade proteinuria was an unexpected adverse event specific to the treatment arm of our clinical trial investigating lipoic acid supplementation in patients with multiple sclerosis. This observation led to detection of similar patients in our nephrology practice. Here, we describe four biopsy-proven cases of neural epidermal growth factor-like 1 (NELL1)–associated membranous nephropathy following lipoic acid supplementation and a fifth suspected case. Discontinuation of lipoic acid and supportive therapy resulted in remission. [Display omitted]</description><identifier>ISSN: 0085-2538</identifier><identifier>EISSN: 1523-1755</identifier><identifier>DOI: 10.1016/j.kint.2021.10.010</identifier><identifier>PMID: 34662650</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>albuminuria ; Calcium-Binding Proteins ; Dietary Supplements ; EGF Family of Proteins ; glomerulonephritis ; Glomerulonephritis, Membranous - diagnosis ; Glomerulonephritis, Membranous - drug therapy ; Humans ; kidney biopsy ; kidney pathology ; lipoic acid ; membranous nephropathy ; nephrotic syndrome ; proteinuria ; Proteinuria - chemically induced ; Proteinuria - drug therapy ; Thioctic Acid - adverse effects</subject><ispartof>Kidney international, 2021-12, Vol.100 (6), p.1208-1213</ispartof><rights>2021</rights><rights>Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-785e1192a52a1299466c80279a622baf1510961d96886bb47ae638ab1ded99633</citedby><cites>FETCH-LOGICAL-c455t-785e1192a52a1299466c80279a622baf1510961d96886bb47ae638ab1ded99633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34662650$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Spain, Rebecca I.</creatorcontrib><creatorcontrib>Andeen, Nicole K.</creatorcontrib><creatorcontrib>Gibson, Pamela C.</creatorcontrib><creatorcontrib>Samuels, Mary H.</creatorcontrib><creatorcontrib>Morris, Cynthia D.</creatorcontrib><creatorcontrib>Solomon, Andrew J.</creatorcontrib><creatorcontrib>Solomon, Richard</creatorcontrib><creatorcontrib>Waslo, Carin</creatorcontrib><creatorcontrib>Avasare, Rupali S.</creatorcontrib><title>Lipoic acid supplementation associated with neural epidermal growth factor-like 1 (NELL1)–associated membranous nephropathy</title><title>Kidney international</title><addtitle>Kidney Int</addtitle><description>Lipoic acid (alpha lipoic acid, thioctic acid) is a popular over-the-counter antioxidant and insulin-mimetic supplement under investigation in a variety of conditions including multiple sclerosis, diabetes, and schizophrenia. Unfortunately, high-grade proteinuria was an unexpected adverse event specific to the treatment arm of our clinical trial investigating lipoic acid supplementation in patients with multiple sclerosis. This observation led to detection of similar patients in our nephrology practice. Here, we describe four biopsy-proven cases of neural epidermal growth factor-like 1 (NELL1)–associated membranous nephropathy following lipoic acid supplementation and a fifth suspected case. Discontinuation of lipoic acid and supportive therapy resulted in remission. [Display omitted]</description><subject>albuminuria</subject><subject>Calcium-Binding Proteins</subject><subject>Dietary Supplements</subject><subject>EGF Family of Proteins</subject><subject>glomerulonephritis</subject><subject>Glomerulonephritis, Membranous - diagnosis</subject><subject>Glomerulonephritis, Membranous - drug therapy</subject><subject>Humans</subject><subject>kidney biopsy</subject><subject>kidney pathology</subject><subject>lipoic acid</subject><subject>membranous nephropathy</subject><subject>nephrotic syndrome</subject><subject>proteinuria</subject><subject>Proteinuria - chemically induced</subject><subject>Proteinuria - drug therapy</subject><subject>Thioctic Acid - adverse effects</subject><issn>0085-2538</issn><issn>1523-1755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UcFOGzEQtVARBMoP9FDtsT1ssL2xY0tVpQpBQVrRS3u2Zu0JcciuV7YD4lCp_8Af8iV1FED00pPHz_Pe-M0j5AOjU0aZPF1Nb_2Qp5xyVoApZXSPTJjgTc3mQrwjE0qVqLlo1CE5SmlFy1039IAcNjMpuRR0Qn63fgzeVmC9q9JmHNfY45Ah-zBUkFKwHjK66t7nZTXgJsK6wtE7jH2pbmK4L_gCbA6xXvtbrFj16fq8bdnnpz-Pb_g99l2EIWxSURmXMYyQlw_vyf4C1glPns9j8uvi_OfZZd3--H519q2t7UyIXM-VQMY0B8GBca3L762ifK5Bct7BgglGtWROS6Vk183mgLJR0DGHTmvZNMfk60533HQ9OlscFiNmjL6H-GACePPvy-CX5ibcGSW5UkIVAb4TsDGkFHHxymXUbMMwK7MNw2zD2GIljEL6-HbqK-Vl-6Xhy64Bi_c7j9Ek63Gw6HxEm40L_n_6fwHpmp8o</recordid><startdate>20211201</startdate><enddate>20211201</enddate><creator>Spain, Rebecca I.</creator><creator>Andeen, Nicole K.</creator><creator>Gibson, Pamela C.</creator><creator>Samuels, Mary H.</creator><creator>Morris, Cynthia D.</creator><creator>Solomon, Andrew J.</creator><creator>Solomon, Richard</creator><creator>Waslo, Carin</creator><creator>Avasare, Rupali S.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20211201</creationdate><title>Lipoic acid supplementation associated with neural epidermal growth factor-like 1 (NELL1)–associated membranous nephropathy</title><author>Spain, Rebecca I. ; Andeen, Nicole K. ; Gibson, Pamela C. ; Samuels, Mary H. ; Morris, Cynthia D. ; Solomon, Andrew J. ; Solomon, Richard ; Waslo, Carin ; Avasare, Rupali S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-785e1192a52a1299466c80279a622baf1510961d96886bb47ae638ab1ded99633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>albuminuria</topic><topic>Calcium-Binding Proteins</topic><topic>Dietary Supplements</topic><topic>EGF Family of Proteins</topic><topic>glomerulonephritis</topic><topic>Glomerulonephritis, Membranous - diagnosis</topic><topic>Glomerulonephritis, Membranous - drug therapy</topic><topic>Humans</topic><topic>kidney biopsy</topic><topic>kidney pathology</topic><topic>lipoic acid</topic><topic>membranous nephropathy</topic><topic>nephrotic syndrome</topic><topic>proteinuria</topic><topic>Proteinuria - chemically induced</topic><topic>Proteinuria - drug therapy</topic><topic>Thioctic Acid - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Spain, Rebecca I.</creatorcontrib><creatorcontrib>Andeen, Nicole K.</creatorcontrib><creatorcontrib>Gibson, Pamela C.</creatorcontrib><creatorcontrib>Samuels, Mary H.</creatorcontrib><creatorcontrib>Morris, Cynthia D.</creatorcontrib><creatorcontrib>Solomon, Andrew J.</creatorcontrib><creatorcontrib>Solomon, Richard</creatorcontrib><creatorcontrib>Waslo, Carin</creatorcontrib><creatorcontrib>Avasare, Rupali S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Kidney international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Spain, Rebecca I.</au><au>Andeen, Nicole K.</au><au>Gibson, Pamela C.</au><au>Samuels, Mary H.</au><au>Morris, Cynthia D.</au><au>Solomon, Andrew J.</au><au>Solomon, Richard</au><au>Waslo, Carin</au><au>Avasare, Rupali S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lipoic acid supplementation associated with neural epidermal growth factor-like 1 (NELL1)–associated membranous nephropathy</atitle><jtitle>Kidney international</jtitle><addtitle>Kidney Int</addtitle><date>2021-12-01</date><risdate>2021</risdate><volume>100</volume><issue>6</issue><spage>1208</spage><epage>1213</epage><pages>1208-1213</pages><issn>0085-2538</issn><eissn>1523-1755</eissn><abstract>Lipoic acid (alpha lipoic acid, thioctic acid) is a popular over-the-counter antioxidant and insulin-mimetic supplement under investigation in a variety of conditions including multiple sclerosis, diabetes, and schizophrenia. Unfortunately, high-grade proteinuria was an unexpected adverse event specific to the treatment arm of our clinical trial investigating lipoic acid supplementation in patients with multiple sclerosis. This observation led to detection of similar patients in our nephrology practice. Here, we describe four biopsy-proven cases of neural epidermal growth factor-like 1 (NELL1)–associated membranous nephropathy following lipoic acid supplementation and a fifth suspected case. Discontinuation of lipoic acid and supportive therapy resulted in remission. [Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34662650</pmid><doi>10.1016/j.kint.2021.10.010</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0085-2538
ispartof Kidney international, 2021-12, Vol.100 (6), p.1208-1213
issn 0085-2538
1523-1755
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8628858
source MEDLINE; Alma/SFX Local Collection
subjects albuminuria
Calcium-Binding Proteins
Dietary Supplements
EGF Family of Proteins
glomerulonephritis
Glomerulonephritis, Membranous - diagnosis
Glomerulonephritis, Membranous - drug therapy
Humans
kidney biopsy
kidney pathology
lipoic acid
membranous nephropathy
nephrotic syndrome
proteinuria
Proteinuria - chemically induced
Proteinuria - drug therapy
Thioctic Acid - adverse effects
title Lipoic acid supplementation associated with neural epidermal growth factor-like 1 (NELL1)–associated membranous nephropathy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T03%3A08%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lipoic%20acid%20supplementation%20associated%20with%20neural%20epidermal%20growth%20factor-like%201%20(NELL1)%E2%80%93associated%20membranous%20nephropathy&rft.jtitle=Kidney%20international&rft.au=Spain,%20Rebecca%20I.&rft.date=2021-12-01&rft.volume=100&rft.issue=6&rft.spage=1208&rft.epage=1213&rft.pages=1208-1213&rft.issn=0085-2538&rft.eissn=1523-1755&rft_id=info:doi/10.1016/j.kint.2021.10.010&rft_dat=%3Celsevier_pubme%3ES0085253821009467%3C/elsevier_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34662650&rft_els_id=S0085253821009467&rfr_iscdi=true